Premature testification is not a laughing matter

All opinions are my own and do not necessarily reflect those of Novo Nordisk.

“These studies, once validated, open an opportunity for creating tests that an expectant mother can take to see if she is producing these autoantibodies. ”

I wrote this statement back in July as part of a post describing the report that maternal autoantibodies to specific neural proteins correlated with the appearance of autism symptoms in the children of those mothers.  Little did I suspect that plans to create a test were already in the works.  Science recently reported (paywall) that researchers behind this study are teaming up with a testing company to develop and market a diagnostic test for maternal autoantibodies.

On the one hand I am much in favor of prognostic tests that will help us anticipate health problems.  I believe in many cases early knowledge and interventions can be helpful, even when there is no “cure.”  One of the hopes for the wave of genomic biomedical research going on now is that it will allow us to better estimate who will and will not come down with specific diseases based on clues in individuals’ DNA.  But on the other hand, it can be problematic when tests are created and released before the underlying biomedical hypothesis has been strongly vetted and supported. Continue reading

Fear versus fear: understanding vaccination rates

All opinions are my own and do not necessarily reflect those of Novo Nordisk.

h/t to @edyong209 for the heads up on the study.

If it seems like plagues from bygone years are coming back, well, you’re right!  Due to growing objections within the United States to vaccination efforts, we are seeing a number of infectious diseases arising that even ten years ago we might have said were eradicated in the US.   The problem may seem larger than it is simply because we get so much more news so much more quickly and easily than we used to.  However, so far there have been 159 cases of measles, which is the highest yearly count since the mid-90s.  And there are still 3.5 months to go in 2013.  Texas has been in the news quite a bit recently for clusters of measles and whooping cough–both diseases with good vaccines that prevent infection when used correctly.

There are a number of reasons why parents choose not to vaccinate their children and one of these seems to be a lack of familiarity with these preventable diseases.  Once almost everyone got the measles and kids got really sick; some died.  Now, the idea of infectious diseases might seem quaint, distant and nonthreatening to parents with no frame of reference.  And of course, once a child gets a disease it’s too late.  A particularly scary report suggests even some younger doctors feel that infectious diseases aren’t such a big deal.

So you might think that this recent study, and others like it showing that the Human Papilloma Virus (HPV) vaccine is clearly reducing HPV infections throughout the body should be promoted even more strongly by public health officials.  Why?  Because HPV is known to cause cancer.  And if there’s anything that evokes the immediacy of fear in the area of health issues, it’s cancer.  That may not be the correct path however, and I’ll get to that in a minute, but first I just want to talk about the research.

The research study was a double-blinded clinical trial in which  7,466 women were inoculated at random with either an HPV vaccine or a control vaccine to hepatitis A.  At the end of the trial, the women were checked for evidence of oral HPV infections.  The vaccine had an estimated vaccine efficacy of about 93%, meaning it reduced infection rates about 14-15 fold.  This study is the first to demonstrate that HPV vaccinations can prevent oral HPV infections in addition to those at the cervix and other locations, as has been shown previously in other research.

That HPV infection is linked causally to the development of some cancers has been shown repeatedly.  Oral HPV infections contribute to the majority of oropharyngeal cancers. When these vaccines were developed, this was the basic argument:  that giving this vaccine to women would result in a decrease in HPV infections and subsequently a decrease in various cancers.  However, as has happened with many vaccines such as the Measles-Mumps-Rubella (MMR) shot, the scientific rationale became overshadowed by a number of other, unanticipated societal factors.

With the HPV vaccine, as Beth Skwarecki (@BethSkw) astutely pointed out on PLOS Blogs, maybe the key issue that wasn’t given enough attention in planning the vaccine rollout is that they way you get HPV is by having sex, and the age at which you should ideally give a person a vaccine is when they are 11 to 12 years old.  Or, to think about it another way, just when girls are starting to begin the maturation process into young women and parents have to face the reality that there is a good chance their child will be having sex sometime in the next 5-10 years.

And that’s scary.  Scarier than the possibility that your child might get cancer 20, 30 years down the road because he or she did not get vaccinated for HPV.  Beth also helpfully links to writing by David Ropeik about how fear can trump common sense with respect to things like, for example, vaccines.

It’s already known that people are lousy about understanding probability, and when you add an element of fear to this misunderstanding, one can see how vaccination campaigns even for something as straightforward as HPV face an uphill battle.

I mean, cancer!  If you can’t get people behind a preventative measure for cancer, what can you do?

And that is the question.  It’s not enough to just say that vaccinations should be mandated.  Sure government could do that, but the consequences could be quite large in terms of anger and pushback.  Would it have helped if in the beginning Merck had not pressed so strongly for every girl to be vaccinated?  Maybe, as some analyses after the fact suggest Merck involvement increased suspicion that all this was just some Pharma boondoggle.  That’s a post-hoc justification though, which I tend to distrust.

Ultimately it seems the answer will have to come from some combination of using subtler methods for incentivizing parents and better understanding of what people are afraid of.  Because right now it seems like even the fear of cancer isn’t enough.

Priming the pump: Biopharma contributions and prescribing patterns

All opinions are my own and do not necessarily reflect those of Novo Nordisk.

How in control are we of the decisions we make every day?  How sure are we of our judgement, how we feel, what we believe?  I think many people would say they feel very in control and very certain.  I suspect many people are wrong.  Studies in behavioral psychology have begun identifying the effect of priming–how a subtle stimulus can affect how people, behave or think.  The field of priming is not without ongoing controversy, but at the same time the effect of priming has been seen in many studies (like this one) and appears to be a real phenomenon, albeit one that is still very challenging to clearly describe, test and validate.

Its in this context that a recent report describing physician prescribing patterns is particularly interesting.  And disturbing.  The study by Joseph Engelberg, Christopher Parsons and Nathan Tefft looked at the effect of Biopharma payments to what drugs doctors prescribe.  To quote from their introduction for some context:  “While such rent-seeking behavior [such as pushing more expensive merchandise by salespeople] might not surprise many people…that financial conflicts of interest could influence their doctor’s advice might be both less expected and more worrisome…intrinsic motivation is thought to be important in medicine, with the goal of optimizing patient health being a paramount objective.”  The null hypothesis would be that prescribing patterns would be related solely to health condition, general information about drug efficacy, and price to the patient.  That’s not what was found. Continue reading

Gaming to help beat cancer

All opinions my own and do not necessarily reflect those of Novo Nordisk.

Plants versus Zombies 2: It’s About Time just came out.  My son spent a significant fraction of his weekend playing it on my iPad.  Okay, fine, I did too.  It’s a lot of fun, it challenges (but not too much) and it teaches you facts like, uh, like that Egyptian society in the past had a real fascination with pyramids.

So it’s not the most educational of games.

Which is why I was stoked to see the writeup of Re-Mission 2 in FierceBiotechIT.  This game takes elements of cancer treatment and places them in the context of a game that both educates patients undergoing cancer treatment as well as provides them a way to feel more in control of their situation.  Version 2 also builds on the impact of the first Re-Mission game, which showed success in improving adherence of patients to their treatment regimens.  Adherence is an important element of medical treatment and trying to make sure people take their medicines is an ongoing problem as we try to improve the efficiency of our healthcare systems.

In addition to behavioral metrics being changed by Re-Mission, functional Magnetic Resonance Imaging (fMRI) also showed that playing the game activated brain areas associated with motivation–again, tying gameplay to elements of adherence.  Some brain region activations also correlated with subject described positive and improved attitudes towards chemotherapy after gameplay. Continue reading

Batman, Blockbusters, and Biopharma

All opinions are my own and do not necessarily reflect those of Novo Nordisk.

This blogging thing is interesting.  I’m discovering one of the challenges with blogging on a regular basis is the back and forth tidal pull between length/quality and speed/relevance.  There are measured, thought-out, lengthy pieces I’m working on about things and concepts I am interested in exploring.  But at the same time I find myself responding to current events that spark a thought and connection, an Aha! moment, with quick reaction pieces.  Finding that balance is tough, especially since I like both kinds of writing and think they add to the general blog environment that I’m trying to create.  And time is limited.  In a given week I shoot for maybe 3+ posts, in an effort not to get too burnt out or disenchanted in the way described by Chuq van Rospach.  Sometimes, though, a combination of thoughts, articles and other bits of information come together and I find myself staying up to pound out those 500 or 1000 words to capture an idea in the moment.  All for the benefit of the 3 or so people who will skim this post, plus the random butt-click registered by some poodle sitting on an iPad.

But whatever.

So, Batman. Continue reading